Unicorn Pharmachem Private Limited, a active private limited company, was established on 07 July 2005 in Kandivali West, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230MH2005PTC154558. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹3.59 Cr.
It upholds a compliant status. Its leadership includes Raj Mohan Appalacharya Nallan Chakravarty (Director), Vijay Indravadan Dave (Director), Bhavesh Vallabhdas Shah (Director). Past directors included Raj Mohan Appalacharya Nallan Chakravarty, Vijay Indravadan Dave. It holds ₹7.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 302, Laxmi Villa Appt., M G Rd.,, Opp. Kala Hanuman Temple,, Kandivali West, Maharashtra, 400067.
U24230MH2005PTC154558
154558
07 July 2005
₹10.00 Cr
₹3.59 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Unicorn Pharmachem Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raj Mohan Appalacharya Nallan Chakravarty | Director | 16 Feb 2008 | Current |
| Vijay Indravadan Dave | Director | 16 Feb 2008 | Current |
| Bhavesh Vallabhdas Shah | Director | 07 Jul 2005 | Current |
| Jatin Vallabhdas Shah | Director | 07 Jul 2005 | Current |
| Kamal Surya Patcha | Director | 07 Jul 2005 | Current |
| Haridasan Raman | Director | 07 Jul 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unicorn Pharmachem Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 15.49% decrease. The company also saw a substantial improvement in profitability, with a 132.04% increase in profit. The company's net worth moved up by a moderate rise of 6.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Unicorn Pharmachem had a promoter holding of 87.74% and a public holding of 12.25%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹71,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2011 | The Saraswat Co-Operative Bank Ltd | ₹1.10 Cr | Open |
| 12 Mar 2010 | Others | ₹6.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Unicorn Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Unicorn Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unicorn Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Unicorn Pharmachem Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Unicorn Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity A charge with Others of Rs. 6.00 Cr registered on 12 Mar 2010 with Charge ID 10212228 was modified on 06 Oct 2022. was completed.
A charge with The Saraswat Co-Operative Bank Ltd amounted to Rs. 1.10 Cr with Charge ID 10291935 was registered on 27 May 2011. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 6.00 Cr with Charge ID 10212228 was registered on 12 Mar 2010. was completed.
Progress on Raj Mohan Appalacharya Nallan Chakravarty was appointed as a Director was appointed as a Director on 16 Feb 2008 & has been associated with this company since 17 years 9 months . was documented.
The CIN of Unicorn Pharmachem Private Limited is U24230MH2005PTC154558.
Unicorn Pharmachem Private Limited is headquartered at 302, Laxmi Villa Appt., M G Rd.,, Opp. Kala Hanuman Temple,, Kandivali West, Maharashtra, 400067.
Unicorn Pharmachem Private Limited was incorporated on 07 July 2005.
The current directors of Unicorn Pharmachem Private Limited are
The primary industry of Unicorn Pharmachem Private Limited is Trade.
Unicorn Pharmachem Private Limited is unlisted.
The authorized capital of Unicorn Pharmachem Private Limited is ₹10.00 Cr, and the paid-up capital is ₹3.59 Cr.
The compliance status of Unicorn Pharmachem Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX